Pathogenesis of NASH: Animal Models

Clinics in Liver Disease

Volumn 11, Issue 1, 2007, Pages 55-74

  London, Roslyn M ^a,b   George, Jacob ^a,b,c  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 N PROPYLTHIAZOLIDINE 4 CARBOXYLIC ACID; ACARBOSE; ACETYLCYSTEINE; ACYL COENZYME A OXIDASE; ADIPONECTIN; AMBROXOL; ANTIOXIDANT; CARBOXYLIC ACID DERIVATIVE; CELECOXIB; COPPER DERIVATIVE; COPPER DIISOPROPYL SALICYLATE; CURCUMIN; INSULIN; LEPTIN; MANGANESE DERIVATIVE; MANGANESE TETRAKIS(5,10,15,20 BENZOIC ACID); METHIONINE ADENOSYLTRANSFERASE; NUCLEAR RESPIRATORY FACTOR 1; PENTOXIFYLLINE; PHOSPHATASE; PIRINIXIC ACID; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DNA MODIFICATION; FATTY ACID SYNTHESIS; FATTY LIVER; GENETIC MODEL; HEPATITIS; HORMONE BLOOD LEVEL; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; REVIEW; STEATOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; FATTY LIVER; HEPATITIS; HUMANS;

EID: 34249681974     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2007.02.010     Document Type: Review

References (60)

1. Sanyal A.J. Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2 1 (2005) 46-53
2. Brunt E.M. Pathology of nonalcoholic steatohepatitis. Hepatol Res 33 2 (2005) 68-71
3. Ratziu V., Charlotte F., Heurtier A., et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128 7 (2005) 1898-1906
4. Janiec D.J., Jacobson E.R., Freeth A., et al. Histologic variation of grade and stage of non-alcoholic fatty liver disease in liver biopsies. Obes Surg 15 4 (2005) 497-501
5. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 6 (2005) 1313-1321
6. Day C., and Saksena S. Non-alcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol 17 Suppl 3 (2002) S377-S384
7. Koteish A., and Diehl A.M. Animal models of steatosis. Semin Liver Dis 21 1 (2001) 89-104
8. den Boer M., Voshol P.J., Kuipers F., et al. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol 24 4 (2004) 644-649
9. Farrell G.C. Animal models of steatohepatitis. In: Farrell G.C., George J., Hall Pde L., et al. (Eds). Fatty liver disease: NASH and related disorders (2005), Blackwell, Carlton, Australia 91-108
10. Anstee Q.M., and Goldin R.D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87 1 (2006) 1-16
11. Fan C.Y., Pan J., Chu R., et al. Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J Biol Chem 271 40 (1996) 24698-24710
12. Hashimoto T., Fujita T., Usuda N., et al. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J Biol Chem 274 27 (1999) 19228-19236
13. Lu S.C., Alvarez L., Huang Z.Z., et al. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A 98 10 (2001) 5560-5565
14. Martinez-Chantar M.L., Corrales F.J., Martinez-Cruz L.A., et al. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J 16 10 (2002) 1292-1294
15. Xu Z., Chen L., Leung L., et al. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci U S A 102 11 (2005) 4120-4125
16. Stiles B., Wang Y., Stahl A., et al. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. [corrected]. Proc Natl Acad Sci U S A 101 7 (2004) 2082-2087
17. Horie Y., Suzuki A., Kataoka E., et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest 113 12 (2004) 1774-1783
18. Sato W., Horie Y., Kataoka E., et al. Hepatic gene expression in hepatocyte-specific Pten deficient mice showing steatohepatitis without ethanol challenge. Hepatol Res 34 4 (2006) 256-265
19. Weltman M.D., Farrell G.C., and Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111 6 (1996) 1645-1653
20. Leclercq I.A., Farrell G.C., Field J., et al. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105 8 (2000) 1067-1075
21. Ip E., Farrell G.C., Robertson G., et al. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38 1 (2003) 123-132
22. George J., Pera N., Phung N., et al. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol 39 5 (2003) 756-764
23. Kirsch R., Clarkson V., Shephard E.G., et al. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol 18 11 (2003) 1272-1282
24. Ip E., Farrell G., Hall P., et al. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 39 5 (2004) 1286-1296
25. Leclercq I.A., Farrell G.C., Sempoux C., et al. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol 41 6 (2004) 926-934
26. Dela Pena A., Leclercq I., Field J., et al. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129 5 (2005) 1663-1674
27. Yu J., Ip E., Dela Pena A., et al. COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator. Hepatology 43 4 (2006) 826-836
28. Sahai A., Malladi P., Melin-Aldana H., et al. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 287 1 (2004) G264-G273
29. McCuskey R.S., Ito Y., Robertson G.R., et al. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 40 2 (2004) 386-393
30. Starkel P., Sempoux C., Leclercq I., et al. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol 39 4 (2003) 538-546
31. Rinella M.E., and Green R.M. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 40 1 (2004) 47-51
32. Schattenberg J.M., Wang Y., Singh R., et al. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J Biol Chem 280 11 (2005) 9887-9894
33. Gao D., Wei C., Chen L., et al. Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am J Physiol Gastrointest Liver Physiol 287 5 (2004) G1070-G1077
34. Lieber C.S., Leo M.A., Mak K.M., et al. Model of nonalcoholic steatohepatitis. Am J Clin Nutr 79 3 (2004) 502-509
35. Seki S., Kitada T., Yamada T., et al. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37 1 (2002) 56-62
36. Deng Q.G., She H., Cheng J.H., et al. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 42 4 (2005) 905-914
37. Li Z., Soloski M.J., and Diehl A.M. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42 4 (2005) 880-885
38. Li Z., Lin H., Yang S., et al. Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. Gastroenterology 123 4 (2002) 1304-1310
39. Ito M., Suzuki J., Sasaki M., et al. Development of nonalcoholic steatohepatitis model through combination of high-fat diet and tetracycline with morbid obesity in mice. Hepatol Res 34 2 (2006) 92-98
40. Sahai A., Malladi P., Pan X., et al. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 287 5 (2004) G1035-G1043
41. Carmiel-Haggai M., Cederbaum A.I., and Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. Faseb J 19 1 (2005) 136-138
42. Arsov T., Larter C.Z., Nolan C.J., et al. Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice. Biochem Biophys Res Commun 342 4 (2006) 1152-1159
43. Lee C.H., Olson P., and Evans R.M. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144 6 (2003) 2201-2207
44. Kashireddy P.V., and Rao M.S. Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis. Hepatol Res 30 2 (2004) 104-110
45. Kirsch R., Clarkson V., Verdonk R.C., et al. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency. J Gastroenterol Hepatol 21 (2006) 174-182
46. Tomita K., Tamiya G., Ando S., et al. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55 3 (2006) 415-424
47. Schattenberg J.M., Singh R., Wang Y., et al. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43 1 (2006) 163-172
48. Sundaram S.S., Whitington P.F., and Green R.M. Steatohepatitis develops rapidly in transgenic mice overexpressing Abcb11 and fed a methionine-choline-deficient diet. Am J Physiol Gastrointest Liver Physiol 288 6 (2005) G1321-G1327
49. Figge A., Lammert F., Paigen B., et al. Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis. J Biol Chem 279 4 (2004) 2790-2799
50. Yoshimatsu M., Terasaki Y., Sakashita N., et al. Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process. Int J Exp Pathol 85 6 (2004) 335-343
51. Tous M., Ferre N., Camps J., et al. Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Mol Cell Biochem 268 1-2 (2005) 53-58
52. Shiri-Sverdlov R., Wouters K., Gorp P.J., et al. Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. J Hepatol 44 4 (2006) 732-741
53. Chen Y., Hozawa S., Sawamura S., et al. Deficiency of inducible nitric oxide synthase exacerbates hepatic fibrosis in mice fed high-fat diet. Biochem Biophys Res Commun 326 1 (2005) 45-51
54. Gomez-Ambrosi J., Becerril S., Oroz P., et al. Reduced adipose tissue mass and hypoleptinemia in iNOS deficient mice: effect of LPS on plasma leptin and adiponectin concentrations. FEBS Lett 577 3 (2004) 351-356
55. Ribeiro P.S., Cortez-Pinto H., Sola S., et al. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 99 9 (2004) 1708-1717
56. DeAngelis R.A., Markiewski M.M., Taub R., et al. A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha. Hepatology 42 5 (2005) 1148-1157
57. Koppe S.W., Sahai A., Malladi P., et al. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. J Hepatol 41 4 (2004) 592-598
58. Lieber C.S., Leo M.A., Mak K.M., et al. Acarbose attenuates experimental non-alcoholic steatohepatitis. Biochem Biophys Res Commun 315 3 (2004) 699-703
59. Oz H.S., Im H.J., Chen T.S., et al. Glutathione-enhancing agents protect against steatohepatitis in a dietary model. J Biochem Mol Toxicol 20 1 (2006) 39-47
60. Laurent A., Nicco C., Tran Van Nhieu J., et al. Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology 39 5 (2004) 1277-1285